Trials / Completed
CompletedNCT00034112
Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- National Center for Complementary and Integrative Health (NCCIH) · NIH
- Sex
- —
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if osteopathic manipulative treatment (OMT) is effective for persons with emphysema as a component of their chronic obstructive pulmonary disease.
Detailed description
OMT sessions are designed to improve chest wall compliance and diaphragmatic function which produce an immediate positive change in pulmonary function parameters and chest wall mobility. This research project will be a significant step in expanding the understanding of the role of OMT in the treatment of chronic lung disease. It is expected to yield evidence that OMT is an important adjunctive modality that improves pulmonary function, increases exercise tolerance, relieves dyspnea, and improves quality of life in those with COPD, and that would have widespread clinical application plus significant economic benefits. Participants in this study will be randomly assigned to receive either OMT or sham treatments once a week for 13 weeks. Outcome measures will be obtained at baseline; immediately following the first treatment; at 4, 8, and 12 weeks after initiation of treatment; and 4 weeks after termination of the treatment. Outcome variables include pulmonary function tests; quality-of-life questionnaires (including emotional functioning, fatigue, and dyspnea); and measurements of exercise tolerance and chest wall mobility.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | osteopathic manipulative treatment |
Timeline
- Start date
- 2001-04-01
- Completion
- 2002-03-01
- First posted
- 2002-04-23
- Last updated
- 2006-08-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00034112. Inclusion in this directory is not an endorsement.